SterileAtlas Marketplaces

DiscoveryAcademic Preclinical Labs Process Dev (PDO)CDMOs

ClinicalCROs Clinical Sites Ethics / IRB Central Labs

QualityPharmacovigilance Regulatory Engineering Consultants

SupplySuppliers Equipment Packaging

DistributionLogistics Distribution Specialty Pharmacy

AccessPayers PBM

CapitalInvestors IP & Legal

SterileAtlasIntelligence Mission Control

Loading…

SterileAtlas

One marketplace for the entire drug lifecycle — global sterile pharmaceutical & biotech manufacturing intelligence.

Marketplaces

All 22 marketplaces
CDMOs
CROs
Clinical trial sites
Consultants

Opportunities

Projects, jobs & leads
Open projects
Jobs
Consulting leads

Platform

Pricing
About us
List your company
Mission Control

© 2026 SterileAtlas · Capability scores are deterministic, rules-based — not AI.

About us Terms Usage Policy Disclosures Compliance Community guidelines Privacy Cookies Refunds DPA Trust & security

Data shown across the platform is illustrative and unverified — not for vendor qualification or regulatory use.

Clinical Development

CROs

Clinical research organizations

38

CROs listed

Trial management, monitoring, biostatistics and data services — scored on real operational depth, not sales polish.

SearchFaceted, over real records CompareSide-by-side scorecards Post an RFxGet qualified responses CollaborateRun it in a shared room AI assistantYour organisation, this market

Scores are deterministic, rules-based — not AI.

MarketplacesCROs

38 providers

Sort

Sterile focus Clinical scale Active trials Name

Regulatory regions

FDA23 EMA16 PMDA15 MHRA11 NMPA11 Health Canada4

Services

Data management23 Biostatistics22 Bioanalytical / labs21 CTMS / study management19 Pharmacovigilance19 Clinical monitoring18 Medical writing16 Patient recruitment14 Regulatory affairs14 Site feasibility14 Real-world evidence5

Therapeutic areas

Oncology20 Immunology18 Neurology14 Cardiometabolic12 Rare disease11 Cell & gene therapy5 Vaccines5 Infectious Diseases3 Respiratory3 Dermatology2 diabetology2 Neuroscience2 ADCs1 and Oncology".1 Biosimilar Development1 Biosimilars1 Biosimilars and Vaccines as therapeutic areas1 bispecifics1 CAR-T/CAR-NK models) and pharmacology areas of immunology & inflammation1 cardiology1 Cardiovascular & Metabolic Disorders1 CDX1 Cell & Gene Therapies1 Cell and Gene Therapies1

Modalities

Small molecules31 Biologics28 Cell & gene therapy14 Antibody-drug conjugates13 Sterile injectables8 Vaccines6 Other4 mRNA / LNP3 Radiopharmaceuticals1

Status

Sterile-pharma focus14 Accepting sponsors38

Countries covered

Any coverage ≥ 10 countries ≥ 25 countries ≥ 40 countries

Site network

Any network ≥ 2,000 sites ≥ 5,000 sites ≥ 15,000 sites

Active trials

Any volume ≥ 100 active ≥ 250 active ≥ 500 active

Region

Asia10 Europe8 North America6 China5 Japan5 United States4

Showing 1 of 38Clear filters Rare disease Biosimilar Development Other

London, United Kingdom · Europe

34sterile

OncologyRare disease

FDAEMAPMDAMHRA

SCALE 230 studies

Open to sponsorsSelective